Drug Channels
APRIL 15, 2025
We also offer licenses to our secure hosted learning environmentno internal setup required! Sorry, individual licenses are not currently available.) The Economics of Retail, Mail, and Specialty Pharmacies Gain a clear-eyed view of how different pharmacy channels generate revenue and manage costs.
Drug Channels
FEBRUARY 21, 2023
As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. If you have any questions before purchasing a license to the report, please email me.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
MARCH 15, 2022
Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more.
Drug Channels
MARCH 18, 2025
Pharmacies and PBMs, Examining $683 Billion Market Review pricing/license options and download the full 2025 report Order before March 31, 2025 to receive special discounted pricing! Note: All license versions include exhibits within the text.) drug pricing, reimbursement, and dispensing system.
The Pharma Data
OCTOBER 27, 2020
License-related fees (5). License-related fees (5). The BREEZE study (NCT03950739) seeks to evaluate 45 patients on a stable dose of Tyvaso after switching to our new dry powder inhaler (DPI) form of treprostinil, which we licensed from MannKind Corporation. .
Drug Channels
FEBRUARY 22, 2022
As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. This 2022 edition addresses COVID-19 and its ongoing impact on the pharmacy and PBM industries.
Drug Channels
OCTOBER 19, 2020
Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?
Expert insights. Personalized for you.
52 
Let's personalize your content